Skip to main content
. Author manuscript; available in PMC: 2024 Jul 20.
Published in final edited form as: Neonatology. 2023 Jul 20;120(5):661–665. doi: 10.1159/000531242

Fig. 1. Anemia, hyperbilirubinemia, and persistent thrombocytopenia associated with pyruvate kinase deficiency.

Fig. 1.

This neonate exhibited thrombocytopenia, anemia, and hyperbilirubinemia despite blood product and exchange transfusions. Trends for (a) platelets (b) hemoglobin and reticulocytes (c) bilirubin, and (d) transaminases are plotted at indicated days of life. Additional laboratory results from day of life (DOL) 0 are also shown in Table 1.